found that M2-Exo miR-365 impairs gemcitabine activation by upregulating the nucleotide pool of triphosphates in cancer cells and inducing cytidine deaminase, thereby significantly reducing the sensitivity of PDAC cells to gemcitabine (154). Here, CDA is linked to cancer.